Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial-Reference-Cited by-同舟云学术

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial

Published:2014-07 Issue:8 Volume:15 Page:809-818
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Vora Ajay,Goulden Nick,Mitchell Chris,Hancock Jeremy,Hough Rachael,Rowntree Clare,Moorman Anthony V,Wade Rachel

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer—Childhood Leukemia Cooperative Group;Cave;N Engl J Med,1998

2. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood;van Dongen;Lancet,1998

3. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia;Coustan-Smith;Lancet,1998

4. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study;Conter;Blood,2010

5. Treating childhood acute lymphoblastic leukemia without cranial irradiation;Pui;N Engl J Med,2009

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study;Leukemia;2024-09-11

2. Clinical analysis of immune reconstitution after chemotherapy in children with acute lymphoblastic leukemia;BMC Pediatrics;2024-08-30

3. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?;Blood Reviews;2024-08

4. Clinical Outcomes of Pediatric Acute Lymphoblastic Leukemia in the Bajio Region of Mexico: A Retrospective Cohort Study;Indian Journal of Hematology and Blood Transfusion;2024-05-18

5. Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in low- and middle-income countries;Leukemia;2024-05-18